Murphy JE - Search Results

1

Treatment of experimental asthma by long-term gene therapy directed against IL-4 and IL-13.

Zavorotinskaya T, Tomkinson A, Murphy JE. Zavorotinskaya T, et al. Among authors: murphy je. Mol Ther. 2003 Feb;7(2):155-62. doi: 10.1016/s1525-0016(02)00050-3. Mol Ther. 2003. PMID: 12597903 Free article.

2

Expression of human coagulation factor VIII in a human hybrid cell line, HKB11.

Mei B, Chen Y, Chen J, Pan CQ, Murphy JE. Mei B, et al. Among authors: murphy je. Mol Biotechnol. 2006 Oct;34(2):165-78. doi: 10.1385/MB:34:2:165. Mol Biotechnol. 2006. PMID: 17172662

3

Lectin binding assays for in-process monitoring of sialylation in protein production.

Xu W, Chen J, Yamasaki G, Murphy JE, Mei B. Xu W, et al. Among authors: murphy je. Mol Biotechnol. 2010 Jul;45(3):248-56. doi: 10.1007/s12033-010-9272-7. Mol Biotechnol. 2010. PMID: 20379804

4

Rational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatment.

Mei B, Pan C, Jiang H, Tjandra H, Strauss J, Chen Y, Liu T, Zhang X, Severs J, Newgren J, Chen J, Gu JM, Subramanyam B, Fournel MA, Pierce GF, Murphy JE. Mei B, et al. Among authors: murphy je. Blood. 2010 Jul 15;116(2):270-9. doi: 10.1182/blood-2009-11-254755. Epub 2010 Mar 1. Blood. 2010. PMID: 20194895 Free article.

5

Over-expression of Hsp70 in BHK-21 cells engineered to produce recombinant factor VIII promotes resistance to apoptosis and enhances secretion.

Ishaque A, Thrift J, Murphy JE, Konstantinov K. Ishaque A, et al. Among authors: murphy je. Biotechnol Bioeng. 2007 May 1;97(1):144-55. doi: 10.1002/bit.21201. Biotechnol Bioeng. 2007. PMID: 17054114

6

Cell surface staining of recombinant factor VIII is reduced in apoptosis resistant BHK-21 cells.

Ishaque A, Thrift J, Murphy JE, Konstantinov K. Ishaque A, et al. Among authors: murphy je. J Biotechnol. 2008 Oct 10;137(1-4):20-7. doi: 10.1016/j.jbiotec.2008.07.1856. Epub 2008 Jul 25. J Biotechnol. 2008. PMID: 18703095

7

Identification and function probing of an antithrombin IIIβ conformation-specific antibody.

Jin Y, Yegneswaran S, Gu JM, Gritzan U, Schönfeld DL, Paz P, Patel C, Dittmer F, Strerath M, Bringmann P, Kauser K, Myles T, Murphy JE, Hermiston TW. Jin Y, et al. Among authors: murphy je. J Thromb Haemost. 2016 Feb;14(2):356-65. doi: 10.1111/jth.13198. Epub 2016 Jan 6. J Thromb Haemost. 2016. PMID: 26581031 Free article.

8

Noncovalent stabilization of the factor VIII A2 domain enhances efficacy in hemophilia A mouse vascular injury models.

Leong L, Sim D, Patel C, Tran K, Liu P, Ho E, Thompson T, Kretschmer PJ, Wakabayashi H, Fay PJ, Murphy JE. Leong L, et al. Among authors: murphy je. Blood. 2015 Jan 8;125(2):392-8. doi: 10.1182/blood-2014-02-555656. Epub 2014 Oct 20. Blood. 2015. PMID: 25331117 Free PMC article.

9

Glycoengineered factor IX variants with improved pharmacokinetics and subcutaneous efficacy.

Brooks AR, Sim D, Gritzan U, Patel C, Blasko E, Feldman RI, Tang L, Ho E, Zhao XY, Apeler H, Murphy JE. Brooks AR, et al. Among authors: murphy je. J Thromb Haemost. 2013 Sep;11(9):1699-706. doi: 10.1111/jth.12300. J Thromb Haemost. 2013. PMID: 23692404 Free article.

10

Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94-9027) for haemophilia A.

Gu JM, Ramsey P, Evans V, Tang L, Apeler H, Leong L, Murphy JE, Laux V, Myles T. Gu JM, et al. Among authors: murphy je. Haemophilia. 2014 Jul;20(4):593-600. doi: 10.1111/hae.12374. Epub 2014 Jan 29. Haemophilia. 2014. PMID: 24471985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

317 results

Search Page

Filters